iNtRON Biotechnology Inc (048530) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, iNtRON Biotechnology Inc (048530) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-993.53 Million ≈ $-673.30K USD) by net assets (₩73.98 Billion ≈ $50.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

iNtRON Biotechnology Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how iNtRON Biotechnology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 048530 liabilities breakdown for a breakdown of total debt and financial obligations.

iNtRON Biotechnology Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iNtRON Biotechnology Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Emerita Resources Corp V:EMO	-0.014x
Empresas la Polar SA SN:ABC	0.122x
Beyaz Filo Oto Kiralama AS IS:BEYAZ	0.316x
Asetek A/S F:A31	0.018x
BQE Water Inc V:BQE	0.049x
SSF Home Group Berhad KLSE:0287	0.013x
Tanami Gold NL AU:TAM	-0.106x
SEAL Incorporated Bhd KLSE:4286	0.022x

Annual Cash Flow Conversion Efficiency for iNtRON Biotechnology Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of iNtRON Biotechnology Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 048530 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩83.77 Billion ≈ $56.77 Million	₩-138.47 Million ≈ $-93.84K	-0.002x	-105.13%
2023-12-31	₩96.73 Billion ≈ $65.56 Million	₩3.12 Billion ≈ $2.11 Million	0.032x	-42.74%
2022-12-31	₩106.18 Billion ≈ $71.96 Million	₩5.98 Billion ≈ $4.05 Million	0.056x	-65.37%
2021-12-31	₩101.35 Billion ≈ $68.68 Million	₩16.47 Billion ≈ $11.16 Million	0.163x	+94.60%
2020-12-31	₩85.38 Billion ≈ $57.86 Million	₩7.13 Billion ≈ $4.83 Million	0.084x	+767.82%
2019-12-31	₩64.96 Billion ≈ $44.02 Million	₩-812.48 Million ≈ $-550.61K	-0.013x	-111.64%
2018-12-31	₩39.09 Billion ≈ $26.49 Million	₩4.20 Billion ≈ $2.85 Million	0.107x	+159.44%
2017-12-31	₩30.24 Billion ≈ $20.50 Million	₩-5.47 Billion ≈ $-3.71 Million	-0.181x	-91.32%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-4.64 Billion ≈ $-3.15 Million	-0.094x	-291.53%
2015-12-31	₩34.44 Billion ≈ $23.34 Million	₩1.70 Billion ≈ $1.15 Million	0.049x	+277.79%
2012-12-31	₩11.93 Billion ≈ $8.08 Million	₩-331.01 Million ≈ $-224.32K	-0.028x	--

About iNtRON Biotechnology Inc

KQ:048530 Korea Biotechnology

Market Cap

$77.34 Million

₩114.13 Billion KRW

Market Cap Rank

#20176 Global

#1162 in Korea

Share Price

₩3610.00

Change (1 day)

-3.48%

52-Week Range

₩2915.00 - ₩6650.00

All Time High

₩46250.00